Key result
Neostigmine administered 1 to 4 hours after vecuronium increased the TOF ratio in 52 of 60 patients, but decreased it in 8 patients and caused adverse cardiovascular effects in 50%.
Why the study?
Does neostigmine effectively reverse residual neuromuscular block at 1 to 4 hours after a single dose of vecuronium?
Does neostigmine effectively reverse residual neuromuscular block at 1 to 4 hours after a single dose of vecuronium?
Neostigmine can effectively reverse residual neuromuscular block from vecuronium up to 4 hours later, but may paradoxically decrease TOF ratios if given when recovery is already near complete, and carries a high risk of cardiovascular adverse effects.
Answers are grounded in this paper and cite their sources.
Neostigmine may paradoxically worsen block or cause cardiovascular effects; leaves open optimal reversal timing after vecuronium.
The purpose of this study was to measure the degree of residual neuromuscular block at different times after a single dose of vecuronium, and to evaluate the effectiveness of two different doses of neostigmine in antagonizing this residual block.Train-of-four (TOF) ratios were examined for up to 4 h after a single dose of vecuronium, 0.1 mg/kg, in 60 patients during nitrous oxide/isoflurane/fentanyl anesthesia. The effect of neostigmine, 40 micro gram/kg, was studied at 1, 2, 3, or 4 h. The effect of neostigmine, 20 micro gram/kg, was studied at 2 or 4 h after the vecuronium. Before neostigmine administration, the TOF ratio was less than 0.75 in 17 patients (including one patient at 4 h). Neostigmine produced an increase in TOF ratio in 52 patients and a decrease in 8. The TOF ratio decreased after neostigmine only, at 2, 3, or 4 h after vecuronium, when the TOF ratio was >or=to0.9 and when neostigmine 40 micro gram/kg was administered. One patient, at 1 h, had a TOF ratio of 0.00 and this did not reach 0.75 until 57 min after neostigmine, 40 micro gram/kg. There was a high incidence (50%) of adverse cardiovascular effects after both doses of neostigmine. In making the decision as to whether neostigmine should be administered, the risk to the patient of residual neuromuscular block must be balanced against the adverse cardiovascular effects of the neostigmine. (Anesth Analg 1995;80:1168-74)
No takes yet. Share an insight, caveat, or question.
James E. Caldwell (1995) studied Patients undergoing anesthesia (n=60). Neostigmine was evaluated on Train-of-four (TOF) ratio. Neostigmine administered 1 to 4 hours after vecuronium increased the TOF ratio in 52 of 60 patients, but decreased it in 8 patients and caused adverse cardiovascular effects in 50%.
Synapse has enriched 10 related papers. Consider them for comparative context: